
AI Scribes in Australia Face Regulatory Scrutiny as Use Doubles
The story in brief
The federal health department has raised concerns about the use of AI scribes by doctors, as the technology has nearly doubled in adoption in Australia from 22% in August 2024 to 40% in November 2025. The tools, which record and transcribe patient consultations, are classified as medical devices only if they serve a therapeutic purpose, but current safeguards are under scrutiny due to inconsistent oversight across multiple regulators.